Pacific Biosciences of California, Inc. (PACB)
1.505
-0.12
(-7.10%)
USD |
NASDAQ |
Mar 03, 10:09
Pacific Biosciences of California Cash from Investing (Quarterly) : 26.03M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 108.41M |
| Twist Bioscience Corp. | -9.933M |
| Boston Scientific Corp. | -512.00M |
| Intellia Therapeutics, Inc. | 27.53M |
| Enovis Corp. | -12.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -19.07M |
| Free Cash Flow | -118.92M |
| Free Cash Flow Per Share (Quarterly) | -0.066 |
| Free Cash Flow to Equity (Quarterly) | -22.27M |
| Free Cash Flow to Firm (Quarterly) | -18.18M |
| Free Cash Flow Yield | -26.34% |